(Q43040909)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Roberto J Firpi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Manal F Abdelmalek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Consuelo Soldevila-Pico

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Alan Hemming

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Richard Howard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

William Van Der Werf

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Gregory Lauwers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Chen Liu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

James M Crawford

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Gary L Davis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

David R Nelson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

published in

Liver Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1000-1006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12424712%20AND%20SRC:MED&resulttype=core&format=json

Recurrent and new hepatitis C virus infection after liver transplantation

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Long-term outcome of hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Reinfection of liver graft by hepatitis C virus after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Graft loss following liver transplantation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Effectiveness of early alpha-interferon therapy for hepatitis C virus infection recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Banff schema for grading liver allograft rejection: an international consensus document

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968

Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34968